Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Vividion Therapeutics, Inc.
QuantumLeap Healthcare Collaborative
National Institutes of Health Clinical Center (CC)
Amgen
UNICANCER
Weill Medical College of Cornell University
National University Hospital, Singapore
Nurix Therapeutics, Inc.
Shandong Cancer Hospital and Institute
University of California, San Diego
The First Affiliated Hospital of Guangzhou Medical University
Shandong University